Apogee Therapeutics Inc’s recently made public that its Director McKenna Mark C. acquired Company’s shares for reported $0.99 million on Dec 12 ’24. In the deal valued at $49.54 per share,20,000 shares were bought. As a result of this transaction, McKenna Mark C. now holds 20,000 shares worth roughly $0.93 million.
Then, Dambkowski Carl sold 4,540 shares, generating $221,363 in total proceeds. Upon selling the shares at $48.76, the Chief Medical Officer now owns 258,073 shares.
Before that, CARL DAMBKOWSKI bought 18,160 shares. Apogee Therapeutics Inc shares valued at $878,581 were divested by the Officer at a price of $48.38 per share.
Canaccord Genuity initiated its Apogee Therapeutics Inc [APGE] rating to a Buy in a research note published on November 25, 2024; the price target was $89. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. BTIG Research began covering APGE with “Buy” recommendation on December 20, 2023. Wedbush started covering the stock on August 08, 2023. It rated APGE as “an Outperform”.
Price Performance Review of APGE
On Tuesday, Apogee Therapeutics Inc [NASDAQ:APGE] saw its stock fall -2.08% to $46.51. Over the last five days, the stock has lost -1.60%. Apogee Therapeutics Inc shares have risen nearly 69.36% since the year began. Nevertheless, the stocks have risen 68.94% over the past one year. While a 52-week high of $72.29 was reached on 03/13/24, a 52-week low of $27.05 was recorded on 01/08/24. SMA at 50 days reached $50.48, while 200 days put it at $50.39.
Levels Of Support And Resistance For APGE Stock
The 24-hour chart illustrates a support level at 46.44, which if violated will result in even more drops to 45.56. On the upside, there is a resistance level at 47.88. A further resistance level may holdings at 48.44. The Relative Strength Index (RSI) on the 14-day chart is 48.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.59%. Stochastics %K at 49.08% indicates the stock is a holding.
How much short interest is there in Apogee Therapeutics Inc?
A steep rise in short interest was recorded in Apogee Therapeutics Inc stocks on 2024-11-29, growing by 0.55 million shares to a total of 7.36 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.81 million shares. There was a rise of 7.49%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 08, 2023 when TD Cowen began covering the stock and recommended ‘”an Outperform”‘ rating .
